Modelling the Tox21 10 K chemical profiles for in vivo toxicity prediction and mechanism characterization

Nature Communications

Volumn 7, Issue , 2016, Pages

  Huang, Ruili ^a   Xia, Menghang ^a   Sakamuru, Srilatha ^a   Zhao, Jinghua ^a   Shahane, Sampada A ^a   Attene Ramos, Matias ^a   Zhao, Tongan ^a   Austin, Christopher P ^a   Simeonov, Anton ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; ORGANIC COMPOUND;

BIOACTIVITY; BIOASSAY; CONCENTRATION (COMPOSITION); PUBLIC HEALTH; TOXICITY TEST; TOXICOLOGY;

ARTICLE; CHEMICAL ANALYSIS; CLUSTER ANALYSIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PREDICTIVE VALUE; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TOXICITY TESTING; CELL LINE; CHEMISTRY; PROCEDURES; STANDARDS; THEORETICAL MODEL;

ANIMALIA;

CELL LINE; HUMANS; MODELS, THEORETICAL; ORGANIC CHEMICALS; STRUCTURE-ACTIVITY RELATIONSHIP; TOXICITY TESTS;

EID: 84955449812     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10425     Document Type: Article

References (38)

1. Collins, F. S., Gray, G. M., Bucher, J. R. Toxicology. Transforming environmental health protection. Science 319, 906-907 (2008).
2. Kavlock, R. J., Austin, C. P., Tice, R. R. Toxicity testing in the 21st century: implications for human health risk assessment. Risk Anal. 29, 485-487 discussion 492-487 (2009).
3. Tice, R. R., Austin, C. P., Kavlock, R. J., Bucher, J. R. Improving the human hazard characterization of chemicals: a Tox21 update. Environ. Health Perspect. 121, 756-765 (2013).
4. NRC Toxicity Testing in the 21st Century: A Vision and a Strategy (The National Academies Press, 2007).
5. Huang, R. et al. Chemical genomics profiling of environmental chemical modulation of human nuclear receptors. Environ. Health Perspect. 119, 1142-1148 (2011).
6. Shukla, S. J., Huang, R., Austin, C. P., Xia, M. The future of toxicity testing: a focus on in vitro methods using a quantitative high throughput screening platform. Drug Discov. Today 15, 997-1007 (2010).
7. Attene-Ramos, M. S. et al. The Tox21 robotic platform for the assessment of environmental chemicals-from vision to reality. Drug Discov. Today 18, 716-723 (2013).
8. Hsu, C. W. et al. Quantitative high-throughput profiling of environmental chemicals and drugs that modulate farnesoid X receptor. Sci. Rep 4, 6437 (2014).
9. Huang, R. et al. Profiling of the Tox21 10K compound library for agonists and antagonists of the estrogen receptor alpha signaling pathway. Sci. Rep. 4, 5664 (2014).
10. Attene-Ramos, M. S. et al. Profiling of the Tox21 chemical collection for mitochondrial function to identify compounds that acutely decrease mitochondrial membrane potential. Environ. Health Perspect. 123, 49-56 (2015).
11. Zhang, J. H., Chung, T. D., Oldenburg, K. R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4, 67-73 (1999).
12. Babula, P., Masarik, M., Adam, V., Provaznik, I., Kizek, R. From Na\+/K\+-ATPase and cardiac glycosides to cytotoxicity and cancer treatment. Anticancer Agents Med. Chem. 13, 1069-1087 (2013).
13. Abd, T. T., Jacobson, T. A. Statin-induced myopathy: a review and update. Expert Opin. Drug Saf. 10, 373-387 (2011).
14. Vidal, B. et al. The alkylating carcinogen N-methyl-N0-nitro-Nnitrosoguanidine activates the plasminogen activator inhibitor-1 gene through sequential phosphorylation of p53 by ATM and ATR kinases. Thromb. Haemost. 93, 584-591 (2005).
15. Rogers, J. A., Metz, L., Yong, V. W. Review: endocrine disrupting chemicals and immune responses: a focus on bisphenol-A and its potential mechanisms. Mol. Immunol. 53, 421-430 (2012).
16. Medjakovic, S. et al. Effect of nonpersistent pesticides on estrogen receptor, androgen receptor, and aryl hydrocarbon receptor. Environ. Toxicol. 29, 1201-1216 (2013).
17. Kirpichnikov, D., McFarlane, S. I., Sowers, J. R. Metformin: an update. Ann. Intern. Med. 137, 25-33 (2002).
18. Carty, T. J. et al. Ampiroxicam, an anti-inflammatory agent which is a prodrug of piroxicam. Agents Actions 39, 157-165 (1993).
19. Judson, R. et al. Perspectives on validation of high-throughput assays supporting 21st century toxicity testing. ALTEX 30, 51-56 (2013).
20. Huang, R. et al. Characterization of diversity in toxicity mechanism using in vitro cytotoxicity assays in quantitative high throughput screening. Chem. Res. Toxicol. 21, 659-667 (2008).
21. FDA. Innovation or Stagnation: Challenge and Opportunity on the Critical Path to New Medical Products, http://www.fda.gov/ScienceResearch/SpecialTopics/CriticalPathInitiative/CriticalPathOpportunitiesReports/ucm077262.htm (2004).
22. Martic-Kehl, M. I., Schibli, R., Schubiger, P. A. Can animal data predict human outcome? Problems and pitfalls of translational animal research. Eur. J. Nucl. Med. Mol. Imaging 39, 1492-1496 (2012).
23. Walum, E., Nilsson, M., Clemedson, C., Ekwall, B. The MEIC program and its implications for the prediction of acute human systemic toxicity. Alternative Methods Toxicol. Life Sci. 11, 275-282 (1995).
24. Goldberg, A. M., Frazier, J. M. Alternatives to animals in toxicity testing. Sci. Am. 261, 24-30 (1989).
25. Low, Y. S., Sedykh, A., Rusyn, I., Tropsha, A. Integrative approaches for predicting in vivo effects of chemicals from their structural descriptors and the results of short-term biological assays. Curr. Top. Med. Chem. 14, 1356-1364 (2014).
26. Abdo, N. et al. Population-based hazard and concentration-response assessment of chemicals: The 1000 Genomes High-Throughput Screening Study. Environ. Health Perspect. 123, 458-466 (2015).
27. Eduati, F. et al. Prediction of human population responses to toxic compounds by a collaborative competition. Nat. Biotechnol. 33, 933-940 (2015).
28. Huang, R. et al. The NCGC pharmaceutical collection: a comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics. Sci. Transl. Med. 3, 80-16 (2011).
29. Wong, C., Chen, S. The development, application and limitations of breast cancer cell lines to study tamoxifen and aromatase inhibitor resistance. J. Steroid Biochem. Mol. Biol. 131, 83-92 (2012).
30. Chen, S. et al. Cell-based high-throughput screening for aromatase inhibitors in the Tox21 10 K library. Toxicol. Sci. 147, 446-457 (2015).
31. Sakamuru, S. et al. Application of a homogenous membrane potential assay to assess mitochondrial function. Physiol. Genomics 44, 495-503 (2012).
32. Yamamoto, K. N. et al. Characterization of environmental chemicals with potential for DNA damage using isogenic DNA repair-deficient chicken DT40 cell lines. Environ. Mol. Mutagen 52, 547-561 (2011).
33. Fox, J. T. et al. High-throughput genotoxicity assay identifies antioxidants as inducers of DNA damage response and cell death. Proc. Natl Acad. Sci. USA 109, 5423-5428 (2012).
34. Shukla, S. J. et al. Profiling environmental chemicals for activity in the antioxidant response element signaling pathway using a high throughput screening approach. Environ. Health Perspect. 120, 1150-1156 (2012).
35. Inglese, J. et al. Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries. Proc. Natl Acad. Sci. USA 103, 11473-11478 (2006).
36. GHS United Nations, Globally Harmonized System of Classification and Labelling of Chemicals (GHS) http://www.unece.org/fileadmin/DAM/trans/danger/publi/ghs/ghs-rev02/English/03e-part3.pdf (2007).
37. Kohonen, T. Self-organizing neural projections. Neural Netw. 19, 723-733 (2006).
38. Zweig, M. H., Campbell, G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin. Chem. 39, 561-577 (1993).